Bioliberty Ltd has filed a Form D to announce an exempt offering of securities. This filing, dated October 26, 2026, indicates the company's intention to raise capital through this offering. Such moves are significant as they can provide insights into the company's financial strategy and future growth plans.
Bioliberty Ltd is a company that operates under the CIK 0002151818. The company is categorized under the SIC description, although specific details were not provided in the filing. The recent filings include two Form D submissions, with the latest one being on October 26, 2026, and the previous one on August 27, 2026.
The filing states that the effectiveness date for the offering is also October 26, 2026. However, specific details regarding the amount being raised or the terms of the offering were not available in the SEC filing.
This move may affect various stakeholders, including investors looking for opportunities in the market and competitors who may need to respond to Bioliberty's strategic decisions. The filing does not specify what happens next, leaving the future actions of the company open-ended.
Company Information
Bioliberty Ltd is incorporated in the United Kingdom, with its business address located at 3F Canning Exchange, 10 Canning Street, Edinburgh, EH3 8EG. The company's fiscal year ends on June 30, and it operates under the Central Index Key (CIK) number 0002151818.
The filing reveals that the company has an Employer Identification Number (EIN) of 000000000 and is categorized under the SEC filing type 'D'. This type of filing is typically used for private placements of securities, indicating that Bioliberty may be seeking to attract a select group of investors rather than a public offering.
Previous Filings
In addition to the recent Form D submission on October 26, 2026, Bioliberty Ltd had a prior Form D filing on August 27, 2026. The details surrounding the nature and results of these previous offerings are not disclosed in the current filing, leaving a gap in understanding the company's fundraising trajectory.
The filing does not provide specific details regarding the amount being raised or the terms of the offering, which are often critical for potential investors assessing the opportunity.